A statement released earlier today by Vetr Inc. about GNC Holdings Inc (NYSE:GNC) raises the target price to $20.50
- Updated: September 17, 2016
Vetr Inc. raised the target price of GNC Holdings Inc (NYSE:GNC) to $21, stating a possible upside of 0.03%.
Just yesterday GNC Holdings Inc (NYSE:GNC) traded 3.62% lower at $19.91. GNC Holdings Inc’s 50-day average is $20.54 and its two hundred day moving average is $26.02. With the last stock price close down 21.09% from the two hundred day average, compared to the S&P 500 which has decreased -0.01% over the date range. 2,503,579 shares of GNC traded, up from ann average volume of 1,833,490.
See Chart Below:
With a market capitalization of $0.0, GNC Holdings Inc has a PE of 8 with a 52 week low of $18.92 and a one-year high of $45.26.
A total of 13 firms have released a report on GNC. One analyst rate the company a strong buy, four analysts rate the company a buy, eight firms rate the company a hold, 0 rate the company to underperform, and lastly 0 firmsrate the company as sell with a one year target of $33.69
Brief Synopsis About GNC Holdings Inc (NYSE:GNC)
GNC Holdings, Inc. is a specialty retailer of health, wellness and performance products, including vitamins, minerals and herbal supplement products (VMHS), sports nutrition products and diet products. The Company operates in three segments: Retail, Franchising and Manufacturing/Wholesale. The Retail segment includes sales of products to customers at its company-owned stores in the United States, Canada, Puerto Rico and Ireland and through its Websites, GNC.com and LuckyVitamin.com. Its Franchise segment consists of its domestic and international franchise operations. Its Manufacturing/Wholesale segment consists of its manufacturing operations in South Carolina and its wholesale sales business. The Company’s brands include Mega Men, Ultra Mega, Total Lean, Pro Performance and Pro Performance AMP, Beyond Raw, GNC Puredge, GNC GenetixHD and Herbal Plus. The Company offers products through GNC.com, and LuckyVitamin.com and www.drugstore.com.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.